Literature DB >> 29668329

Depressive Symptomatology, Syndromal Depression, and HIV-Associated Neurocognitive Disorder (HAND).

Karl Goodkin1, Scott B Patten2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29668329      PMCID： PMC5912305          DOI： 10.1177/0706743718754537

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  14 in total

1.  Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Authors:  Karl Goodkin; Eric N Miller; Christopher Cox; Sandra Reynolds; James T Becker; Eileen Martin; Ola A Selnes; David G Ostrow; Ned C Sacktor
Journal:  Lancet HIV       Date:  2017-07-14       Impact factor: 12.767

Review 2.  Efavirenz and the CNS: what we already know and questions that need to be answered.

Authors:  Nadezda Apostolova; Haryes A Funes; Ana Blas-Garcia; Maria J Galindo; Angeles Alvarez; Juan V Esplugues
Journal:  J Antimicrob Chemother       Date:  2015-07-22       Impact factor: 5.790

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis.

Authors:  Laura Manea; Simon Gilbody; Dean McMillan
Journal:  CMAJ       Date:  2011-12-19       Impact factor: 8.262

5.  Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.

Authors:  Samanta Simioni; Matthias Cavassini; Jean-Marie Annoni; Aline Rimbault Abraham; Isabelle Bourquin; Véronique Schiffer; Alexandra Calmy; Jean-Philippe Chave; Ezio Giacobini; Bernard Hirschel; Renaud A Du Pasquier
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

6.  Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.

Authors:  Sarah Tymchuk; Daniela Gomez; Noshin Koenig; M John Gill; Esther Fujiwara; Christopher Power
Journal:  Can J Psychiatry       Date:  2017-12-11       Impact factor: 4.356

7.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

8.  Prevalence of Depression in People Living with HIV/AIDS Undergoing ART and Factors Associated with it.

Authors:  M S Bhatia; Sahil Munjal
Journal:  J Clin Diagn Res       Date:  2014-10-20

9.  Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIV.

Authors:  L S Eller; M Rivero-Mendez; J Voss; W-T Chen; P Chaiphibalsarisdi; S Iipinge; M O Johnson; C J Portillo; I B Corless; K Sullivan; L Tyer-Viola; J Kemppainen; C Dawson Rose; E Sefcik; K Nokes; J C Phillips; K Kirksey; P K Nicholas; D Wantland; W L Holzemer; A R Webel; J M Brion
Journal:  AIDS Care       Date:  2013-10-04

10.  Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care.

Authors:  Takeshi Inoue; Teruaki Tanaka; Shin Nakagawa; Yasuya Nakato; Rie Kameyama; Shuken Boku; Hiroyuki Toda; Tsugiko Kurita; Tsukasa Koyama
Journal:  BMC Psychiatry       Date:  2012-07-03       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.